TrialJournal of child and adolescent psychopharmacology2020

Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study.

Ann C Childress et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.